Skin and gut imprinted helper T cell subsets exhibit distinct functional phenotypes in central nervous system autoimmunity
Michael Hiltensperger(TUM Klinikum), Thomas Korn(TUM Klinikum), Sofia Tyystjärvi(TUM Klinikum), Simon Grassmann(Technical University of Munich), Sebastian Jarosch(Boehringer Ingelheim (Germany)), Tania Kümpfel(Ludwig-Maximilians-Universität München), Benjamin Knier(Evangelisches Diakoniekrankenhaus), Bernhard Hemmer(Munich Cluster for Systems Neurology), Garima Garg(Manubhai Patel Dental College and Hospital), Naoto Kawakami(Ludwig-Maximilians-Universität München), Veit R. Buchholz(German Cancer Research Center), Andreas Muschaweckh(TUM Klinikum), Isabel Bauer(Institut für Klinische Neuroimmunologie), Gildas Lepennetier(TUM Klinikum), Rupert Öllinger(Technical University of Munich), Klaus Dornmair(Institute of Neuroimmunology of the Slovak Academy of Sciences), Lisa Ann Gerdes(Munich Cluster for Systems Neurology), Ravi Kant(National Institute of Immunology), Dirk H. Busch(German Center for Infection Research), Helena Domínguez Moreno(TUM Klinikum), Thomas Misgeld(Harvard University), Sören Franzenburg(University Hospital Schleswig-Holstein), Selin Kenet(Technical University of Munich), Eduardo Beltrán(Munich Cluster for Systems Neurology), Ali Maisam Afzali(Technical University of Munich), Christiane Gasperi, Christopher Sie(Technical University of Munich), Kilian Schober(Friedrich-Alexander-Universität Erlangen-Nürnberg), Roland Rad(ING Direct), Lilian Aly(Technical University of Munich)
Cited by 58
Related Papers
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
|New England Journal of Medicine|2016|1.9k
Multiple sclerosis
|The Lancet|2018|1.8k